Indeed, amplification of the CYP24A1 gene was reported in human breast tumors (Albertson et al., 2000) and analysis of the datasets from The Cancer Genome Atlas confirms that a subset of human breast cancers (10–13%) exhibit alterations in the CYP24 gene, with the most frequent changes being amplifications and upregulation at the mRNA level (Table 1). This evidence concerns the gene CYP24A1 and breast cancer.